Medicinal Products

Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete

Name Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete
Marketing Authorisation Number HR-H-263764683
Active Substance abacavirum, lamivudinum
Pharmaceutical Form filmom obložena tableta
Strength 600 mg + 300 mg
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-263764683-01]
10 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-263764683-02]
30 tableta u blisteru, u kutiji  [HR-H-263764683-03]
30 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-263764683-04]
90 tableta u blisteru, u kutiji  [HR-H-263764683-05]
90 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-263764683-06]
Manufacturer Pliva Hrvatska d.o.o., Zagreb, Hrvatska
Teva Pharma B.V., Haarlem, Nizozemska
Merckle GmbH, Ulm, Njemačka
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date 10.07.2020
MA Period of Validity unlimited
Classification Number UP/I-530-09/20-02/43
Registration Number 381-12-01/154-20-03
Composition svaka filmom obložena tableta sadrži 600 mg abakavira i 300 mg lamivudina
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code J05AR02
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Prezentacija za zdravstvene radnike, verzija 3
Back